Skip to main content
UniHealth

Doctor search

Chen Wang, MD

Dermatology · Stanford

NPI 1801280359

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
15
3 carriers
Offices
5

Offices

5 locations · Stanford Health Care · Direct Dermatology Professionals PC

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

15 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

15 of 15 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A143851 · Current

Licensed to practise in California · since 2016 · expires 2028-04-30 · Yale University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$86,965

Medicare paid this office $86,965 for 627 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)158$20,425$96
New patient visit (45+ min)143$19,258$135
New patient visit (30+ min)165$11,004$67
Short return visit (20+ min)135$9,125$51
Destruction of precancer skin growth, 1 growth102$6,357$47
See all 14 services
Every Original Medicare service billed
Return visit (30+ min)158$20,425$96
New patient visit (45+ min)143$19,258$135
New patient visit (30+ min)165$11,004$67
Short return visit (20+ min)135$9,125$51
Destruction of precancer skin growth, 1 growth102$6,357$47
Biopsy of related skin growth, first growth93$5,714$54
Destruction of skin growth, 1-14 growths48$4,362$84
New patient visit (15+ min)72$1,888$26
Destruction of precancer skin growth, 2-14 growths80$1,372$3
Punch biopsy, first skin growth14$1,005$67
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's48$861$15
Biopsy of related skin growth, each additional growth17$795$33
Injection into skin growth, 1-7 growths13$597$33
Short return visit (20+ min)15$477$32

Procedures Medicare counted

Procedure volume Medicare published
Removal of skin lesions834More than 91% of doctors who do this
Removal or shaving of skin growth25More than 73% of doctors who do this
Skin biopsy281More than 90% of doctors who do this

Who their Medicare patients are

627 Original Medicare patients in 2024. Average age 71 · Under 65 12% · 85 and older 9% · Women 55% · Also on Medicaid 40% · Health risk score 1.18. Above the middle of the specialty; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 64% · Diabetes 29% · Chronic kidney disease 23% · Coronary heart disease 20% · Depression 19% · Atrial fibrillation 15% · Cancer 14% · Heart failure 12% · COPD 10% · Dementia 7% · Stroke 5%.

The office billed $413,152, Medicare allowed $122,315 and paid $86,965; for 1,713 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20246271,713711.18$413,152$86,965
20234521,047701.34$205,927$43,842
2022298985721.34$152,096$36,460
2021262930721.26$172,634$36,133
2020225785741.54$129,484$23,177
201995375741.46$35,344$10,444

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Return visit (30+ min)82$9,022$78
New patient visit (45+ min)68$7,741$114
New patient visit (30+ min)128$6,689$52
Short return visit (20+ min)98$5,452$46
Destruction of precancer skin growth, 1 growth59$3,249$47
Destruction of skin growth, 1-14 growths35$2,274$60
New patient visit (15+ min)65$1,872$29
Short return visit (20+ min)24$1,335$51
Biopsy of related skin growth, first growth48$1,203$23
Return visit (30+ min)11$813$63
Destruction of precancer skin growth, 2-14 growths47$487$2

2022: 11 services

Original Medicare services billed in 2022
Return visit (30+ min)101$10,724$82
Short return visit (20+ min)96$6,031$52
Destruction of precancer skin growth, 1 growth73$3,620$41
New patient visit (45+ min)34$3,564$105
Destruction of skin growth, 1-14 growths48$3,049$54
New patient visit (30+ min)39$2,223$57
Biopsy of related skin growth, first growth46$1,105$22
New patient visit (15+ min)28$1,017$36
Short return visit (20+ min)14$928$55
Destruction of precancer skin growth, 2-14 growths56$562$2
Biopsy of related skin growth, each additional growth18$457$20

2021: 9 services

Original Medicare services billed in 2021
New patient visit (45+ min)69$8,075$117
Return visit (30+ min)82$7,311$73
Short return visit (20+ min)50$3,363$51
Destruction of skin growth, 1-14 growths39$2,949$58
Destruction of precancer skin growth, 1 growth68$2,898$38
New patient visit (30+ min)34$2,195$65
Short return visit (20+ min)29$1,640$51
Biopsy of related skin growth, first growth34$829$22
Destruction of precancer skin growth, 2-14 growths60$453$2

2020: 13 services

Original Medicare services billed in 2020
Return visit (30+ min)77$5,796$72
Destruction of precancer skin growth, 1 growth55$2,458$45
New patient visit (30+ min)40$2,394$60
Destruction of skin growth, 1-14 growths31$2,081$63
Short return visit (20+ min)37$1,924$46
Return visit (30+ min)21$1,459$66
New patient visit (30+ min)21$903$43
Destruction of precancer skin growth, 1 growth24$768$32
Short return visit (20+ min)25$626$25
Biopsy of related skin growth, first growth20$450$21
Destruction of precancer skin growth, 2-14 growths47$409$2
Biopsy of related skin growth, first growth12$258$22
Destruction of precancer skin growth, 2-14 growths21$145$1

2019: 6 services

Original Medicare services billed in 2019
Short return visit (20+ min)50$2,511$46
New patient visit (30+ min)28$1,892$68
Destruction of precancer skin growth, 1 growth36$1,680$47
Destruction of skin growth, 1-14 growths21$1,478$67
Destruction of precancer skin growth, 2-14 growths32$349$2
Biopsy of related skin growth, first growth13$271$21

Medicaid work

$341,203 in 2024

Medicaid paid $341,203 for 5,714 billed services this clinician did in 2024, up to 237 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
OFF/OP CONSLTJ NEW/EST SF 201,855$142,030
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES2,030$123,370
Short return visit (20+ min)652$39,848
New patient visit (30+ min)660$20,149
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES217$7,877
Return visit (30+ min)111$5,600
OFF/OP CNSLTJ NEW/EST MOD 4014$1,964
New patient visit (45+ min)12$365
Medication list documented in medical record (COA)100$0
Other evaluation and management service63$0
Medicaid work by year
20245,71410237$341,203
20235,9337222$291,703
20225,3247208$300,015
20218667156$42,146
202027214$1,764
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes1,143$96,985
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES1,876$69,162
OFF/OP CONSLTJ NEW/EST SF 201,305$59,634
Short return visit (20+ min)624$32,415
New patient visit (30+ min)636$23,788
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES254$7,885
Return visit (30+ min)95$1,834

2022

Largest Medicaid services in 2022
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes2,023$171,424
OFF/OP CONSLTJ NEW/EST SF 201,353$62,363
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES1,091$33,885
New patient visit (30+ min)248$11,692
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES242$9,141
Short return visit (20+ min)242$6,419
Return visit (30+ min)125$5,091

2021

Largest Medicaid services in 2021
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes288$24,480
OFF/OP CONSLTJ NEW/EST SF 20133$6,088
New patient visit (45+ min)54$5,193
Return visit (30+ min)67$3,404
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES165$1,068
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES12$990
Short return visit (20+ min)147$923

2020

Largest Medicaid services in 2020
New patient visit (30+ min)13$1,110
Return visit (30+ min)14$654

Drugs they prescribed that Part D paid

$1,432,313

Pharmacies billed $1,432,313 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,829) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

1,571 generic and 258 brand-name prescriptions · $1,432,313 in drug cost · 69 antibiotic prescriptions to 38 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Skyrizi15$313,022$20,868
Dupixent54$281,418$5,211
Cosentyx Sensoready (2 Pens)26$182,918$7,035
Dupixent42$168,534$4,013
Otezla31$149,101$4,810
See all 35 drugs
Every Part D drug this clinician prescribed
Skyrizi15$313,022$20,868
Dupixent54$281,418$5,211
Cosentyx Sensoready (2 Pens)26$182,918$7,035
Dupixent42$168,534$4,013
Otezla31$149,101$4,810
Humira15$84,478$5,632
Clobetasol Propionate177$8,598$49
Fluocinonide127$5,179$41
Ketoconazole171$2,893$17
Fluorouracil31$2,723$88
Tacrolimus28$2,538$91
Permethrin41$2,303$56
Triamcinolone Acetonide258$2,268$9
Metronidazole37$1,730$47
Clindamycin Phosphate50$1,402$28
Ciclopirox60$1,361$23
Ciclopirox42$1,348$32
Doxycycline Hyclate56$1,342$24
Betamethasone Dipropionate27$1,113$41
Tretinoin18$1,028$57
Betamethasone Diprop Augmented23$1,014$44
Desonide20$1,008$50
Fluocinolone Acetonide11$796$72
Minoxidil61$757$12
Hydroxychloroquine Sulfate11$745$68
Mupirocin77$744$10
Doxepin13$452$35
Ivermectin14$416$30
Fluconazole20$406$20
Finasteride19$374$20
Hydrocortisone35$322$9
Valacyclovir12$305$25
Hydroxyzine17$168$10
Prednisone25$93$4
Terbinafine32$83$3

Year by year

Part D prescribing by year
20241,8294890% (0)14%$1,432,313
20231,3523880% (0)16%$1,241,473
20221,1123330% (0)11%$519,923
20219393190% (0)5%$164,285
20203431680% (0)8%$69,989
201997530% (0)None$20,328
201817None0% (0)0%$589
20162914NoneNone$1,335
201515NoneNoneNone$1,103

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 28 drugs

Part D drugs prescribed in 2023
Cosentyx Sensoready (2 Pens)31$244,113$7,875
Humira(Cf)23$170,807$7,426
Taltz17$153,773$9,045
Dupixent34$145,058$4,266
Otezla21$103,996$4,952
Dupixent11$56,507$5,137
Betamethasone Diprop Augmented118$11,597$98
Clobetasol Propionate106$9,797$92
Fluocinonide61$4,588$75
Triamcinolone Acetonide251$4,090$16
Betamethasone Dipropionate39$3,635$93
Desonide18$3,207$178
Ketoconazole126$2,857$23
Imiquimod13$2,760$212
Metronidazole31$2,671$86
Fluorouracil25$2,318$93
Doxycycline Hyclate44$2,305$52
Clindamycin Phosphate35$1,268$36
Ciclopirox24$1,153$48
Ciclopirox33$1,029$31
Valacyclovir11$702$64
Minoxidil42$572$14
Clotrimazole21$396$19
Mupirocin27$337$12
Hydroxyzine16$211$13
Finasteride14$185$13
Hydrocortisone18$105$6
Terbinafine23$96$4

2022: 26 drugs

Part D drugs prescribed in 2022
Cosentyx Pen (2 Pens)11$101,125$9,193
Dupixent17$56,613$3,330
Dupixent15$52,505$3,500
Betamethasone Diprop Augmented79$9,930$126
Clobetasol Propionate65$7,837$121
Tacrolimus25$5,182$207
Triamcinolone Acetonide239$4,030$17
Fluorouracil29$3,425$118
Betamethasone Dipropionate41$2,622$64
Fluocinonide22$2,307$105
Ketoconazole106$2,052$19
Clindamycin Phosphate42$1,658$39
Metronidazole16$1,235$77
Doxycycline Hyclate32$1,115$35
Ciclopirox18$1,094$61
Ciclopirox23$1,079$47
Econazole Nitrate16$886$55
Hydroxyzine25$472$19
Valacyclovir11$451$41
Gabapentin24$313$13
Mupirocin24$291$12
Minoxidil29$287$10
Hydrocortisone29$245$8
Finasteride19$188$10
Prednisone12$136$11
Terbinafine11$70$6

2021: 21 drugs

Part D drugs prescribed in 2021
Clobetasol Propionate101$8,679$86
Tacrolimus13$4,351$335
Triamcinolone Acetonide241$3,918$16
Betamethasone Diprop Augmented29$2,979$103
Fluorouracil28$2,712$97
Ketoconazole101$2,614$26
Metronidazole21$1,733$83
Fluocinonide12$1,364$114
Econazole Nitrate15$1,241$83
Doxycycline Hyclate15$1,110$74
Hydroxychloroquine Sulfate22$1,081$49
Doxycycline Monohydrate11$771$70
Permethrin11$765$70
Clindamycin Phosphate23$753$33
Hydrocortisone63$503$8
Ciclopirox13$495$38
Gabapentin19$445$23
Clotrimazole18$437$24
Hydroxyzine25$435$17
Finasteride23$334$15
Mupirocin27$238$9

2020: 7 drugs

Part D drugs prescribed in 2020
Clobetasol Propionate26$2,460$95
Triamcinolone Acetonide118$1,991$17
Fluorouracil16$1,955$122
Fluocinonide13$1,088$84
Ketoconazole27$937$35
Doxycycline Hyclate14$361$26
Hydrocortisone24$220$9

2019: 1 drug

Part D drugs prescribed in 2019
Triamcinolone Acetonide32$534$17

Money from drug and device companies

$31 in 2023

Industry payments by year
202312None$31
201911None$115

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
PfizerCibinqo$31
2 payments
  • Education for Cibinqo · 2023-05-10 · $15
  • Education for Cibinqo · 2023-04-12 · $15
See all 2 published payments
Every published payment
PfizerEducation · 2023-05-10Cibinqo$15
PfizerEducation · 2023-04-12Cibinqo$15
See earlier years (2019)

2019: $115

Payments by company in 2019
PfizerEucrisa$115
1 payment
  • Meals for Eucrisa · 2019-04-30 · $115

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
80.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1801280359
Licence
CA A143851California A143851: Current · expires 2028-04-30
Trained
Yale University School of Medicine, 2015
Group
Stanford Health Care · Direct Dermatology Professionals PC
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X)
Mailing address
450 Broadway St Fl C2, Redwood City, CA, 94063
NPI first listed
2015-03-23
NPI last updated
2024-04-16
NPI record certified
2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 450 Broadway St Fl C2, Redwood City, CA, 94063